Call imec.istart 2018
The imec.istart acceleration program just launched its new call for tech start-ups with application deadline 1 October 2018. Use the check list to see if your company meets the necessary criteria. Please…
IOF GEAR call 2018
The Industrial Research Fund (IOF) launches a new call for the Groups of Expertise in Applied Research (GEAR) funding program. This program focuses on building a portfolio of application-oriented knowledge…
Call Kom op tegen Kanker
Kom op tegen Kanker is looking for biomedical research projects to support innovative cancer research that contributes to survival and/or quality of life of cancer patients. Apply here before 28…
The promising future of confobody's
Confobody's are the secret weapon with which VIB-VUB spin-off Confo Therapeutics wants to make untreatable diseases treatable. They were discovered by VUB biologist and professor Jan Steyaert. Read more…
Looking for venture capital in Flanders?
Discover 67 venture capital funds and 7 crowdfunding platforms in VLAIO’s recently updated overview brochure.
VUB AVN PhD in nuclear safety and radiation protection goes to Tim Rubben
The phenomenon of hydrogen induced cracking (HIC) of steel is subject of ongoing debate. Presumed hydrogen induced cracks are playing a key role in the ongoing discussions about the pressure vessels…
Collibra Appoints Michelle Rosen as General Counsel
Collibra, the leader in enterprise data governance and catalog software, announced Michelle Rosen has joined the company as its new General Counsel. Rosen brings to Collibra a wealth of experience in providing…
VUB BruBotics' exoskeletons relieve heavy work
Large companies such as Volvo Trucks and Carglass fully commit to invest in research in exoskeletons. Read the article on VUB Today and the interview with prof. Dirk Lefeber in Knack Trends of today.
Brussels, the start-up hub of Belgium
Brussels offers a lot of advantages for starting companies. About 21 spin-offs have been created since 2006. More here.
Bone cancer research at VUB awarded
VUB researcher Sylvia Faict of the research group Hematology and Immunology group (HEIM) has received the New Investigator Award from the Cancer and Bone Society, as part of her research into Multiple Myeloma.